The field of assisted reproductive treatment is filled with technical terms and acronyms. Here is a list of some common terms you may come across.
This brochure explains what IVF involves and what services may and may not be included in a clinic's fee per IVF cycle.
In Australia, Medicare covers many of the fees associated with a cycle of IVF. The remaining costs vary, depending on an individual's needs, the clinic you attend, and whether you have reached the Extended Medicare Safety Net threshold.
The Assisted Reproductive Treatment Act 2008 (Vic) (Act) prohibits taking donated gametes, or embryos produced from donated gametes, into or outside of Victoria without the written approval of the Victorian Assisted Reproductive Authority (VARTA). Accordingly, approval must be obtained from VARTA before:
• the import of donor gametes, or embryos produced from donor gametes, into Victoria from interstate or overseas;
Intra-cytoplasmic sperm injection (ICSI) is used for the same reasons as IVF, but especially to overcome sperm problems. Essentially, ICSI follows the same process as IVF, except ICSI involves the direct injection of a single sperm into each egg to achieve fertilisation.
This brochure was developed with the help from experts in the IVF field. In the hands of experts, IVF procedures are safe and medical complications are rare. But as with all medical procedures, there are some possible health effects. This brochure provides an overview of the possible physical and emotional health effects of IVF for men and women, and outcomes for children born as a result of treatment. The information refers to IVF and intracytoplasmic sperm injection (ICSI).
This brochure is intended as a general introduction to preimplantation genetic testing (PGT): what it is, how it is done, the reasons for doing PGT, and advantages and disadvantages of PGT. It should not be seen as a substitute for advice from doctors or other health professionals. Information contained in this brochure was correct at the time of writing however as PGT is a rapidly advancing technology it is important to check information with your fertility specialist.
Among embryos created in a laboratory some have too many and some have too few chromosomes. This is called aneuploidy. Embryos can also have genetic defects which can cause health problems in a child. Preimplantation genetic testing (PGT) is used to select embryos with the right number of chromosomes and those that do not have defective genes. There are two types of PGT:
The History of Donor Conception Records in Victoria was prepared for VARTA by Dr Fiona Kelly, Associate Professor in Law at La Trobe University, and Dr Deborah Dempsey, Associate Professor in Sociology at Swinburne University of Technology. The report was supported by the Victorian Government.
This brochure is intended as a general introduction to preimplantation genetic testing for aneuploidy (PGT-A): what it is, how it is done and advantanges and disadvantages of doing PGT-A. It should not be seen as a substitute for advice from doctors or other health professionals. Information contained in this brochure was correct at the time of writing however as PGT-A is a rapidly advancing technology it is important to check information with your fertility specialist.